//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы

De Crevoisier R. et al. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX). Int J Radiat Oncol Biol Phys. 2009;74:1150.

Delaunay B. et al. Brachytherapy for penile cancer: efficacy and impact on sexual function. Brachytherapy. 2014;13:380.

Crook J. et al. Penile brachytherapy: technical aspects and postimplant issues. Brachytherapy. 2010;9:151.

Cordoba A. et al. Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients). Radiat Oncol. 2016;11:96.

Ornellas A.A. et al. Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol. 2008;97:487.

Veeratterapillay R. et al. Oncologic Outcomes of Penile Cancer Treatment at a UK Supraregional Center. Urology. 2015;85:1097.

Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings. Clin Genitourin Cancer. 2016;14:323.

Hakenberg O.W. et al. Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int. 2006;98:1225.

Giannatempo P. et al. Survival analyses of adjuvant or neoadjuvant combination of a taxane plus cisplatin and 5-fluorouracil (T-PF) in patients with bulky nodal metastases from squamous cell carcinoma of the penis (PSCC): Results of a single high-volume center. J Clin Oncol. 2014;32:5.

Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed. Clin Genitourin Cancer. 2016;14:231.